Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample
Abstract
The present invention concerns methods and materials for extracting infectious pathogens from a sample, such as blood, comprising the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The fibrin lysis reagent is preferably composed of plasminogen and streptokinase frozen in coincident relation until the fibrin lysis reagent is needed whereby streptokinase enzymatically reacts with plasminogen to form plasmin upon thawing. Preferably, the plasminogen is suspended in an aqueous salt solution prior to freezing including NaCl and Na 3 PO 4. Thesubject invention also concerns materials and methods for efficiently removing ATA from a sample comprising nucleic acid composition. The subject methods provide a nucleic acid composition sufficiently free of ATA such that a RT-PCR reaction and other reactions involving reverse transcriptase can be performed.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
71 members in 14 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 60477903 | United States of America | A | |
| 60477903 | United States of America | A | |
| 48189204 | United States of America | P | |
| 48189204 | United States of America | P | |
| 2004026606 | United States of America | W | |
| 2004026606 | United States of America | W | |
| 481892P | – | – | – |
| 604779 | – | – | – |
| 0426606 | – | – | – |
| US20030604779 | – | – | – |
| US20040481892P | – | – | – |
| WO2004US26606 | – | – | – |
Members71
| Document | Office | Kind | |
|---|---|---|---|
| US2005014128A1 | United States of America | A1 | |
| AU2004269340A1 | Australia | A1 | |
| WO2005021799A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2005021799A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2005277130A1 | United States of America | A1 | |
| NO20061189L | Norway | L | |
| EP1654387A2 | European Patent Office (EPO) | A2 | |
| JP2007502618A | Japan | A | |
| US7416843B2 | United States of America | B2 | |
| EP1654387B1 | European Patent Office (EPO) | B1 | |
| AT430812TThis record | Austria | T | |
| ATE430812T1 | Austria | T1 | |
| DE602004020999D1 | Germany | D1 | |
| DK1654387T3 | Denmark | T3 | |
| PT1654387E | Portugal | E | |
| ES2325445T3 | Spain | T3 | |
| EP2103694A1 | European Patent Office (EPO) | A1 | |
| EP2112232A1 | European Patent Office (EPO) | A1 | |
| PL1654387T3 | Poland | T3 | |
| SI1654387T1 | Slovenia | T1 | |
| US2009305383A1 | United States of America | A1 | |
| HK1136317A | Hong Kong, China | A | |
| HK1136852A | Hong Kong, China | A | |
| AU2010207760A1 | Australia | A1 | |
| JP2010193901A | Japan | A | |
| AU2004269340B2 | Australia | B2 | |
| JP4662932B2 | Japan | B2 | |
| EP2103694B1 | European Patent Office (EPO) | B1 | |
| AT510931T | Austria | T | |
| ATE510931T1 | Austria | T1 | |
| PT2103694E | Portugal | E | |
| US7993870B2 | United States of America | B2 | |
| US7998699B2 | United States of America | B2 | |
| DK2103694T3 | Denmark | T3 | |
| ES2365976T3 | Spain | T3 | |
| PL2103694T3 | Poland | T3 | |
| US2012034614A1 | United States of America | A1 | |
| AU2010207760B2 | Australia | B2 | |
| US2012164714A1 | United States of America | A1 | |
| AU2012216623A1 | Australia | A1 | |
| JP2013005819A | Japan | A | |
| JP2013005820A | Japan | A | |
| JP2013039134A | Japan | A | |
| AU2013203116A1 | Australia | A1 | |
| AU2013203127A1 | Australia | A1 | |
| US2013109885A1 | United States of America | A1 | |
| AU2013203143A1 | Australia | A1 | |
| US2013115687A1 | United States of America | A1 | |
| US2013122509A1 | United States of America | A1 | |
| US2013130234A1 | United States of America | A1 | |
| US2013130271A1 | United States of America | A1 | |
| US2013130302A1 | United States of America | A1 | |
| US8465966B2 | United States of America | B2 | |
| JP5253451B2 | Japan | B2 | |
| US2013236920A1 | United States of America | A1 | |
| AU2012216623B2 | Australia | B2 | |
| US2013288342A1 | United States of America | A1 | |
| US8574866B2 | United States of America | B2 | |
| US8592200B2 | United States of America | B2 | |
| US8617839B1 | United States of America | B1 | |
| US2014093944A1 | United States of America | A1 | |
| EP2112232B1 | European Patent Office (EPO) | B1 | |
| US2014142047A1 | United States of America | A1 | |
| US8735090B2 | United States of America | B2 | |
| US8759479B2 | United States of America | B2 | |
| US8785176B2 | United States of America | B2 | |
| US8815502B2 | United States of America | B2 | |
| US8916698B2 | United States of America | B2 | |
| US8927243B2 | United States of America | B2 | |
| US8962243B2 | United States of America | B2 | |
| AU2013203143B2 | Australia | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Publication, DOCDB
- 430812
- Publication, EPODOC
- AT430812T
- Application
- 4801986
- Application, DOCDB
- 04801986
- Application, EPODOC
- AT20040801986T
Titles2
- German
- MATERIALIEN UND VERFAHREN ZUM EINFANGEN VON KRANKHEITSERREGERN UND ZUR ABTRENNUNG VON AURINTRICARBONSÄURE AUS EINER PROBE
- English
- MATERIALS AND METHODS FOR THE INJECTION OF DISEASES AND FOR THE SEPARATION OF AURINE TRICACYLIC ACID FROM A SAMPLE
Classification
- CPC, 13
- C07K17/10
- C12Q1/04
- C07C51/42
- C12Q1/56
- C07C65/40
- G01N33/86
- C12M33/00
- C12Q1/6806
- C12N15/1003
- C12N15/1006
- C12N15/101
- C12Q1/24
- G01N1/34
- IPC, 4
- C12Q1 68
- C12Q1 04
- C12Q1 56
- G01N33 86